819. Experience with Isavuconazole Use for Treatment of Invasive Fungal Infections

BACKGROUND: The treatment of invasive fungal infections (IFI) is often complicated by drug-drug interactions, toxicities, and host comorbidities. Isavuconazole (ISA) has a favorable side effect profile and has FDA approval for invasive aspergillosis and mucormycosis, but there are fewer data on its...

Descripción completa

Detalles Bibliográficos
Autores principales: Gow-Lee, Vanessa, Chesdachai, Supavit, Harris, Courtney E, Abu Saleh, Omar M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677956/
http://dx.doi.org/10.1093/ofid/ofad500.864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677956/
http://dx.doi.org/10.1093/ofid/ofad500.864

Ejemplares similares